^ abc“Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2”. Diabetologia55 (10): 2565–82. (October 2012). doi:10.1007/s00125-012-2644-8. PMC 4011499. PMID (22869320). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011499/.
^“Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein”. Science292 (5514): 104–6. (April 2001). doi:10.1126/science.1057991. PMID (11292874).
^“Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice”. FASEB Journal22 (3): 807–18. (March 2008). doi:10.1096/fj.07-9261com. PMID (17928362).
^“Positive and negative regulation of insulin signaling through IRS-1 phosphorylation”. Biochimie87 (1): 99–109. (January 2005). doi:10.1016/j.biochi.2004.10.019. PMID (15733744).
^“Association of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic function”. Molecular Biology of the Cell11 (2): 735–46. (February 2000). doi:10.1091/mbc.11.2.735. PMC 14806. PMID (10679027). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC14806/.
^“The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling”. The EMBO Journal12 (5): 1929–36. (May 1993). doi:10.1002/j.1460-2075.1993.tb05842.x. PMC 413414. PMID (8491186). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC413414/.
^ ab“ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation”. Oncogene21 (37): 5684–95. (August 2002). doi:10.1038/sj.onc.1205669. PMID (12173038).
^“Involvement of Janus kinases in the insulin signaling pathway”. European Journal of Biochemistry / FEBS234 (2): 656–60. (December 1995). doi:10.1111/j.1432-1033.1995.656_b.x. PMID (8536716).
^ ab“Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action”. The Journal of Biological Chemistry277 (2): 1531–7. (January 2002). doi:10.1074/jbc.M101521200. PMID (11606564).
^“Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786”. The Journal of Biological Chemistry271 (11): 5980–3. (March 1996). doi:10.1074/jbc.271.11.5980. PMID (8626379).
^“Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system”. The Journal of Biological Chemistry270 (40): 23456–60. (October 1995). doi:10.1074/jbc.270.40.23456. PMID (7559507).
^“Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10”. Molecular Endocrinology10 (6): 631–41. (June 1996). doi:10.1210/mend.10.6.8776723. PMID (8776723).
^“Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility”. Molecular and Cellular Biology19 (4): 3125–35. (April 1999). doi:10.1128/mcb.19.4.3125. PMC 84106. PMID (10082579). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84106/.
^ ab“Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor”. Endocrinology139 (3): 884–93. (March 1998). doi:10.1210/endo.139.3.5829. PMID (9492017).
^“Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases”. The Journal of Biological Chemistry270 (48): 28527–30. (December 1995). doi:10.1074/jbc.270.48.28527. PMID (7499365).
^“Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation”. The Journal of Experimental Medicine193 (2): 263–9. (January 2001). doi:10.1084/jem.193.2.263. PMC 2193341. PMID (11208867). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193341/.
^“The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)”. The Journal of Biological Chemistry275 (12): 9047–54. (March 2000). doi:10.1074/jbc.275.12.9047. PMID (10722755).
^“Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers”. The Journal of Biological Chemistry267 (25): 17483–6. (September 1992). PMID (1381348).
^“Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes”. The Journal of Biological Chemistry278 (29): 26550–7. (July 2003). doi:10.1074/jbc.M212273200. PMID (12730242).
^“An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events”. Diabetologia45 (5): 657–67. (May 2002). doi:10.1007/s00125-002-0798-5. PMID (12107746).
^“Multiple forms of p55PIK, a regulatory subunit of phosphoinositide 3-kinase, are generated by alternative initiation of translation”. The Biochemical Journal341 (3): 831–7. (August 1999). doi:10.1042/0264-6021:3410831. PMC 1220424. PMID (10417350). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220424/.
^“Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins”. Molecular Endocrinology11 (13): 1911–23. (December 1997). doi:10.1210/mend.11.13.0029. PMID (9415396).
^“Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src)”. The Journal of Biological Chemistry273 (48): 32244–53. (November 1998). doi:10.1074/jbc.273.48.32244. PMID (9822703).
^“The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp”. The Journal of Biological Chemistry268 (16): 11479–81. (June 1993). PMID (8505282).
^“The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling”. The Journal of Biological Chemistry273 (41): 26908–14. (October 1998). doi:10.1074/jbc.273.41.26908. PMID (9756938).
^“Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein”. The Journal of Biological Chemistry275 (6): 4283–9. (February 2000). doi:10.1074/jbc.275.6.4283. PMID (10660596).
^“Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor”. Molecular Endocrinology15 (10): 1768–80. (October 2001). doi:10.1210/mend.15.10.0711. PMID (11579209).
^“14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner”. The Journal of Biological Chemistry272 (17): 11663–9. (April 1997). doi:10.1074/jbc.272.17.11663. PMID (9111084).
^“Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2”. Cell Cycle6 (6): 705–13. (March 2007). doi:10.4161/cc.6.6.4035. PMID (17374994).
^ ab“The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer”. PLoS One7 (4): e36190. (2012-04-27). doi:10.1371/journal.pone.0036190. PMC 3338610. PMID (22558377). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338610/.
^“Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis”. The American Journal of Pathology152 (2): 341–5. (February 1998). PMC 1857952. PMID (9466558). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857952/.
^“Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver”. Hepatology49 (6): 1935–43. (June 2009). doi:10.1002/hep.22856. PMC 2754284. PMID (19475691). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754284/.
^“Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells”. Oncogene20 (4): 490–500. (January 2001). doi:10.1038/sj.onc.1204112. PMID (11313980).
^“Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease”. Cancer Research62 (10): 2942–50. (May 2002). PMID (12019176).
^“PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model”. Human Molecular Genetics10 (6): 605–16. (March 2001). doi:10.1093/hmg/10.6.605. PMID (11230180).
^“Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1”. Bioconjugate Chemistry18 (6): 1831–40. (2007-12-01). doi:10.1021/bc070135v. PMID (17922544).
^“Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation”. Clinical Cancer Research1 (11): 1429–36. (November 1995). PMID (9815941).
^“Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells”. Biochemical and Biophysical Research Communications288 (3): 685–9. (November 2001). doi:10.1006/bbrc.2001.5815. PMID (11676497).
^“Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells”. International Journal of Cancer72 (5): 828–34. (September 1997). doi:10.1002/(sici)1097-0215(19970904)72:5<828::aid-ijc20>3.0.co;2-3. PMID (9311601).
^“The cell growth suppressor, mir-126, targets IRS-1”. Biochemical and Biophysical Research Communications377 (1): 136–40. (December 2008). doi:10.1016/j.bbrc.2008.09.089. PMID (18834857).
^“Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2”. Molecular and Cellular Biology26 (24): 9302–14. (December 2006). doi:10.1128/MCB.00260-06. PMC 1698542. PMID (17030631). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698542/.
^“IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors”. Cancer Letters338 (2): 239–48. (September 2013). doi:10.1016/j.canlet.2013.03.030. PMC 3761875. PMID (23562473). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761875/.
関連文献
“IL-4/IL-13 signaling beyond JAK/STAT”. The Journal of Allergy and Clinical Immunology105 (6 Pt 1): 1063–70. (June 2000). doi:10.1067/mai.2000.107604. PMID (10856136).
“Lack of Arg972 polymorphism in the IRS1 gene in Parakanã Brazilian Indians”. Human Biology76 (1): 147–51. (February 2004). doi:10.1353/hub.2004.0015. PMID (15222685).
“Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis”. Cell Cycle6 (6): 631–7. (March 2007). doi:10.4161/cc.6.6.3987. PMID (17361103).
“Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2”. Cell Cycle6 (6): 705–13. (March 2007). doi:10.4161/cc.6.6.4035. PMID (17374994).